 | • レポートコード：MRC2Q12-03678 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：化学&材料 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、スガマデクスナトリウムAPIのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 スガマデクスナトリウムAPIのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 スガマデクスナトリウムAPIの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 スガマデクスナトリウムAPIのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのスガマデクスナトリウムAPIの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のスガマデクスナトリウムAPIの売上および2028年までの予測に焦点を当てています。 スガマデクスナトリウムAPIのグローバル主要企業には、Transo-Pharm、Rochem International、Dr. Reddy's Laboratories、Extrovis AG、Teva API、Piramal Pharma Solutions、ASolution Pharmaceuticals、BrightGene Bio-Medical Technology、Epoch Labs、Lek Pharmaceuticals、MSN Laboratories、Mankind Pharma、Mylan Inc、Solara Active Pharma Sciences、Viwit Pharmaceuticals、Yonsung Fine Chemicalsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 スガマデクスナトリウムAPI市場は、タイプとアプリケーションによって区分されます。世界のスガマデクスナトリウムAPI市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 0.99、0.995、その他 【アプリケーション別セグメント】 注射、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - スガマデクスナトリウムAPI製品概要 - タイプ別市場（0.99、0.995、その他） - アプリケーション別市場（注射、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のスガマデクスナトリウムAPI販売量予測2017-2028 - 世界のスガマデクスナトリウムAPI売上予測2017-2028 - スガマデクスナトリウムAPIの地域別販売量 - スガマデクスナトリウムAPIの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別スガマデクスナトリウムAPI販売量 - 主要メーカー別スガマデクスナトリウムAPI売上 - 主要メーカー別スガマデクスナトリウムAPI価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（0.99、0.995、その他） - スガマデクスナトリウムAPIのタイプ別販売量 - スガマデクスナトリウムAPIのタイプ別売上 - スガマデクスナトリウムAPIのタイプ別価格 ・アプリケーション別市場規模（注射、その他） - スガマデクスナトリウムAPIのアプリケーション別販売量 - スガマデクスナトリウムAPIのアプリケーション別売上 - スガマデクスナトリウムAPIのアプリケーション別価格 ・北米市場 - 北米のスガマデクスナトリウムAPI市場規模（タイプ別、アプリケーション別） - 主要国別のスガマデクスナトリウムAPI市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのスガマデクスナトリウムAPI市場規模（タイプ別、アプリケーション別） - 主要国別のスガマデクスナトリウムAPI市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のスガマデクスナトリウムAPI市場規模（タイプ別、アプリケーション別） - 主要国別のスガマデクスナトリウムAPI市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のスガマデクスナトリウムAPI市場規模（タイプ別、アプリケーション別） - 主要国別のスガマデクスナトリウムAPI市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのスガマデクスナトリウムAPI市場規模（タイプ別、アプリケーション別） - 主要国別のスガマデクスナトリウムAPI市場規模（トルコ、サウジアラビア） ・企業情報 Transo-Pharm、Rochem International、Dr. Reddy's Laboratories、Extrovis AG、Teva API、Piramal Pharma Solutions、ASolution Pharmaceuticals、BrightGene Bio-Medical Technology、Epoch Labs、Lek Pharmaceuticals、MSN Laboratories、Mankind Pharma、Mylan Inc、Solara Active Pharma Sciences、Viwit Pharmaceuticals、Yonsung Fine Chemicals ・産業チェーン及び販売チャネル分析 - スガマデクスナトリウムAPIの産業チェーン分析 - スガマデクスナトリウムAPIの原材料 - スガマデクスナトリウムAPIの生産プロセス - スガマデクスナトリウムAPIの販売及びマーケティング - スガマデクスナトリウムAPIの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - スガマデクスナトリウムAPIの産業動向 - スガマデクスナトリウムAPIのマーケットドライバー - スガマデクスナトリウムAPIの課題 - スガマデクスナトリウムAPIの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Sugammadex Sodium API estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Sugammadex Sodium API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Sugammadex Sodium API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Sugammadex Sodium API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Sugammadex Sodium API include Transo-Pharm, Rochem International, Dr. Reddy’s Laboratories, Extrovis AG, Teva API, Piramal Pharma Solutions, ASolution Pharmaceuticals, BrightGene Bio-Medical Technology and Epoch Labs, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Sugammadex Sodium API production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Sugammadex Sodium API by region (region level and country level), by company, by Purity and by Application. from 2017 to 2022 and forecast to 2028.
Report Scope
This latest report researches the industry structure, capacity, production, sales (consumption), revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Sugammadex Sodium API manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Sugammadex Sodium API market. Further, it explains the major drivers and regional dynamics of the global Sugammadex Sodium API market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Transo-Pharm
Rochem International
Dr. Reddy’s Laboratories
Extrovis AG
Teva API
Piramal Pharma Solutions
ASolution Pharmaceuticals
BrightGene Bio-Medical Technology
Epoch Labs
Lek Pharmaceuticals
MSN Laboratories
Mankind Pharma
Mylan Inc
Solara Active Pharma Sciences
Viwit Pharmaceuticals
Yonsung Fine Chemicals
Market Segments
This report has explored the key segments: by Purity and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on production, price, and value for the period 2017-2028.
Sugammadex Sodium API Segment by Purity
0.99
0.995
Others
Sugammadex Sodium API Segment by Application
Injection
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. This report analyzes the Sugammadex Sodium API production by region/country, and the sales (consumption) by region/country. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Sugammadex Sodium API market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Sugammadex Sodium API, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Sugammadex Sodium API, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Sugammadex Sodium API, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Sugammadex Sodium API sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Sugammadex Sodium API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Sugammadex Sodium API sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Transo-Pharm, Rochem International, Dr. Reddy’s Laboratories, Extrovis AG, Teva API, Piramal Pharma Solutions, ASolution Pharmaceuticals, BrightGene Bio-Medical Technology and Epoch Labs, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sugammadex Sodium API capacity, production/output of global and key producers (regions/countries). It provides a quantitative analysis of the capacity, production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Sugammadex Sodium API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Sugammadex Sodium API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by purity, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by purity, by application and by country, sales and revenue for each segment.
Chapter 9: Asia Pacific by purity, by application and by country, sales and revenue for each segment.
Chapter 10: Latin America by purity, by application and by country, sales and revenue for each segment.
Chapter 11: Middle East and Africa by purity, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sugammadex Sodium API sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
1 Study Coverage
1.1 Sugammadex Sodium API Product Introduction
1.2 Market by Purity
1.2.1 Global Sugammadex Sodium API Market Size by Purity, 2017 VS 2021 VS 2028
1.2.2 0.99
1.2.3 0.995
1.2.4 Others
1.3 Market by Application
1.3.1 Global Sugammadex Sodium API Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Injection
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Sugammadex Sodium API Production
2.1 Global Sugammadex Sodium API Production Capacity (2017-2028)
2.2 Global Sugammadex Sodium API Production by Region: 2017 VS 2021 VS 2028
2.3 Global Sugammadex Sodium API Production by Region
2.3.1 Global Sugammadex Sodium API Historic Production by Region (2017-2022)
2.3.2 Global Sugammadex Sodium API Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Sugammadex Sodium API Sales in Volume & Value Estimates and Forecasts
3.1 Global Sugammadex Sodium API Sales Estimates and Forecasts 2017-2028
3.2 Global Sugammadex Sodium API Revenue Estimates and Forecasts 2017-2028
3.3 Global Sugammadex Sodium API Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Sugammadex Sodium API Sales by Region
3.4.1 Global Sugammadex Sodium API Sales by Region (2017-2022)
3.4.2 Global Sales Sugammadex Sodium API by Region (2023-2028)
3.5 Global Sugammadex Sodium API Revenue by Region
3.5.1 Global Sugammadex Sodium API Revenue by Region (2017-2022)
3.5.2 Global Sugammadex Sodium API Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Sugammadex Sodium API Production Capacity by Manufacturers
4.2 Global Sugammadex Sodium API Sales by Manufacturers
4.2.1 Global Sugammadex Sodium API Sales by Manufacturers (2017-2022)
4.2.2 Global Sugammadex Sodium API Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Sugammadex Sodium API in 2021
4.3 Global Sugammadex Sodium API Revenue by Manufacturers
4.3.1 Global Sugammadex Sodium API Revenue by Manufacturers (2017-2022)
4.3.2 Global Sugammadex Sodium API Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Sugammadex Sodium API Revenue in 2021
4.4 Global Sugammadex Sodium API Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Sugammadex Sodium API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Sugammadex Sodium API Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Purity
5.1 Global Sugammadex Sodium API Sales by Purity
5.1.1 Global Sugammadex Sodium API Historical Sales by Purity (2017-2022)
5.1.2 Global Sugammadex Sodium API Forecasted Sales by Purity (2023-2028)
5.1.3 Global Sugammadex Sodium API Sales Market Share by Purity (2017-2028)
5.2 Global Sugammadex Sodium API Revenue by Purity
5.2.1 Global Sugammadex Sodium API Historical Revenue by Purity (2017-2022)
5.2.2 Global Sugammadex Sodium API Forecasted Revenue by Purity (2023-2028)
5.2.3 Global Sugammadex Sodium API Revenue Market Share by Purity (2017-2028)
5.3 Global Sugammadex Sodium API Price by Purity
5.3.1 Global Sugammadex Sodium API Price by Purity (2017-2022)
5.3.2 Global Sugammadex Sodium API Price Forecast by Purity (2023-2028)
6 Market Size by Application
6.1 Global Sugammadex Sodium API Sales by Application
6.1.1 Global Sugammadex Sodium API Historical Sales by Application (2017-2022)
6.1.2 Global Sugammadex Sodium API Forecasted Sales by Application (2023-2028)
6.1.3 Global Sugammadex Sodium API Sales Market Share by Application (2017-2028)
6.2 Global Sugammadex Sodium API Revenue by Application
6.2.1 Global Sugammadex Sodium API Historical Revenue by Application (2017-2022)
6.2.2 Global Sugammadex Sodium API Forecasted Revenue by Application (2023-2028)
6.2.3 Global Sugammadex Sodium API Revenue Market Share by Application (2017-2028)
6.3 Global Sugammadex Sodium API Price by Application
6.3.1 Global Sugammadex Sodium API Price by Application (2017-2022)
6.3.2 Global Sugammadex Sodium API Price Forecast by Application (2023-2028)
7 North America
7.1 North America Sugammadex Sodium API Market Size by Purity
7.1.1 North America Sugammadex Sodium API Sales by Purity (2017-2028)
7.1.2 North America Sugammadex Sodium API Revenue by Purity (2017-2028)
7.2 North America Sugammadex Sodium API Market Size by Application
7.2.1 North America Sugammadex Sodium API Sales by Application (2017-2028)
7.2.2 North America Sugammadex Sodium API Revenue by Application (2017-2028)
7.3 North America Sugammadex Sodium API Sales by Country
7.3.1 North America Sugammadex Sodium API Sales by Country (2017-2028)
7.3.2 North America Sugammadex Sodium API Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Sugammadex Sodium API Market Size by Purity
8.1.1 Europe Sugammadex Sodium API Sales by Purity (2017-2028)
8.1.2 Europe Sugammadex Sodium API Revenue by Purity (2017-2028)
8.2 Europe Sugammadex Sodium API Market Size by Application
8.2.1 Europe Sugammadex Sodium API Sales by Application (2017-2028)
8.2.2 Europe Sugammadex Sodium API Revenue by Application (2017-2028)
8.3 Europe Sugammadex Sodium API Sales by Country
8.3.1 Europe Sugammadex Sodium API Sales by Country (2017-2028)
8.3.2 Europe Sugammadex Sodium API Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Sugammadex Sodium API Market Size by Purity
9.1.1 Asia Pacific Sugammadex Sodium API Sales by Purity (2017-2028)
9.1.2 Asia Pacific Sugammadex Sodium API Revenue by Purity (2017-2028)
9.2 Asia Pacific Sugammadex Sodium API Market Size by Application
9.2.1 Asia Pacific Sugammadex Sodium API Sales by Application (2017-2028)
9.2.2 Asia Pacific Sugammadex Sodium API Revenue by Application (2017-2028)
9.3 Asia Pacific Sugammadex Sodium API Sales by Region
9.3.1 Asia Pacific Sugammadex Sodium API Sales by Region (2017-2028)
9.3.2 Asia Pacific Sugammadex Sodium API Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Sugammadex Sodium API Market Size by Purity
10.1.1 Latin America Sugammadex Sodium API Sales by Purity (2017-2028)
10.1.2 Latin America Sugammadex Sodium API Revenue by Purity (2017-2028)
10.2 Latin America Sugammadex Sodium API Market Size by Application
10.2.1 Latin America Sugammadex Sodium API Sales by Application (2017-2028)
10.2.2 Latin America Sugammadex Sodium API Revenue by Application (2017-2028)
10.3 Latin America Sugammadex Sodium API Sales by Country
10.3.1 Latin America Sugammadex Sodium API Sales by Country (2017-2028)
10.3.2 Latin America Sugammadex Sodium API Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sugammadex Sodium API Market Size by Purity
11.1.1 Middle East and Africa Sugammadex Sodium API Sales by Purity (2017-2028)
11.1.2 Middle East and Africa Sugammadex Sodium API Revenue by Purity (2017-2028)
11.2 Middle East and Africa Sugammadex Sodium API Market Size by Application
11.2.1 Middle East and Africa Sugammadex Sodium API Sales by Application (2017-2028)
11.2.2 Middle East and Africa Sugammadex Sodium API Revenue by Application (2017-2028)
11.3 Middle East and Africa Sugammadex Sodium API Sales by Country
11.3.1 Middle East and Africa Sugammadex Sodium API Sales by Country (2017-2028)
11.3.2 Middle East and Africa Sugammadex Sodium API Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Transo-Pharm
12.1.1 Transo-Pharm Corporation Information
12.1.2 Transo-Pharm Overview
12.1.3 Transo-Pharm Sugammadex Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Transo-Pharm Sugammadex Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Transo-Pharm Recent Developments
12.2 Rochem International
12.2.1 Rochem International Corporation Information
12.2.2 Rochem International Overview
12.2.3 Rochem International Sugammadex Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Rochem International Sugammadex Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Rochem International Recent Developments
12.3 Dr. Reddy’s Laboratories
12.3.1 Dr. Reddy’s Laboratories Corporation Information
12.3.2 Dr. Reddy’s Laboratories Overview
12.3.3 Dr. Reddy’s Laboratories Sugammadex Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Dr. Reddy’s Laboratories Sugammadex Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Dr. Reddy’s Laboratories Recent Developments
12.4 Extrovis AG
12.4.1 Extrovis AG Corporation Information
12.4.2 Extrovis AG Overview
12.4.3 Extrovis AG Sugammadex Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Extrovis AG Sugammadex Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Extrovis AG Recent Developments
12.5 Teva API
12.5.1 Teva API Corporation Information
12.5.2 Teva API Overview
12.5.3 Teva API Sugammadex Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Teva API Sugammadex Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Teva API Recent Developments
12.6 Piramal Pharma Solutions
12.6.1 Piramal Pharma Solutions Corporation Information
12.6.2 Piramal Pharma Solutions Overview
12.6.3 Piramal Pharma Solutions Sugammadex Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Piramal Pharma Solutions Sugammadex Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Piramal Pharma Solutions Recent Developments
12.7 ASolution Pharmaceuticals
12.7.1 ASolution Pharmaceuticals Corporation Information
12.7.2 ASolution Pharmaceuticals Overview
12.7.3 ASolution Pharmaceuticals Sugammadex Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 ASolution Pharmaceuticals Sugammadex Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 ASolution Pharmaceuticals Recent Developments
12.8 BrightGene Bio-Medical Technology
12.8.1 BrightGene Bio-Medical Technology Corporation Information
12.8.2 BrightGene Bio-Medical Technology Overview
12.8.3 BrightGene Bio-Medical Technology Sugammadex Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 BrightGene Bio-Medical Technology Sugammadex Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 BrightGene Bio-Medical Technology Recent Developments
12.9 Epoch Labs
12.9.1 Epoch Labs Corporation Information
12.9.2 Epoch Labs Overview
12.9.3 Epoch Labs Sugammadex Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Epoch Labs Sugammadex Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Epoch Labs Recent Developments
12.10 Lek Pharmaceuticals
12.10.1 Lek Pharmaceuticals Corporation Information
12.10.2 Lek Pharmaceuticals Overview
12.10.3 Lek Pharmaceuticals Sugammadex Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Lek Pharmaceuticals Sugammadex Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Lek Pharmaceuticals Recent Developments
12.11 MSN Laboratories
12.11.1 MSN Laboratories Corporation Information
12.11.2 MSN Laboratories Overview
12.11.3 MSN Laboratories Sugammadex Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 MSN Laboratories Sugammadex Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 MSN Laboratories Recent Developments
12.12 Mankind Pharma
12.12.1 Mankind Pharma Corporation Information
12.12.2 Mankind Pharma Overview
12.12.3 Mankind Pharma Sugammadex Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
12.12.4 Mankind Pharma Sugammadex Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Mankind Pharma Recent Developments
12.13 Mylan Inc
12.13.1 Mylan Inc Corporation Information
12.13.2 Mylan Inc Overview
12.13.3 Mylan Inc Sugammadex Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
12.13.4 Mylan Inc Sugammadex Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Mylan Inc Recent Developments
12.14 Solara Active Pharma Sciences
12.14.1 Solara Active Pharma Sciences Corporation Information
12.14.2 Solara Active Pharma Sciences Overview
12.14.3 Solara Active Pharma Sciences Sugammadex Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
12.14.4 Solara Active Pharma Sciences Sugammadex Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 Solara Active Pharma Sciences Recent Developments
12.15 Viwit Pharmaceuticals
12.15.1 Viwit Pharmaceuticals Corporation Information
12.15.2 Viwit Pharmaceuticals Overview
12.15.3 Viwit Pharmaceuticals Sugammadex Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
12.15.4 Viwit Pharmaceuticals Sugammadex Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
12.15.5 Viwit Pharmaceuticals Recent Developments
12.16 Yonsung Fine Chemicals
12.16.1 Yonsung Fine Chemicals Corporation Information
12.16.2 Yonsung Fine Chemicals Overview
12.16.3 Yonsung Fine Chemicals Sugammadex Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
12.16.4 Yonsung Fine Chemicals Sugammadex Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
12.16.5 Yonsung Fine Chemicals Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Sugammadex Sodium API Industry Chain Analysis
13.2 Sugammadex Sodium API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Sugammadex Sodium API Production Mode & Process
13.4 Sugammadex Sodium API Sales and Marketing
13.4.1 Sugammadex Sodium API Sales Channels
13.4.2 Sugammadex Sodium API Distributors
13.5 Sugammadex Sodium API Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Sugammadex Sodium API Industry Trends
14.2 Sugammadex Sodium API Market Drivers
14.3 Sugammadex Sodium API Market Challenges
14.4 Sugammadex Sodium API Market Restraints
15 Key Finding in The Global Sugammadex Sodium API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer